Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats. 2005

Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
Medical Psychology Unit, Department of Psychiatry and Forensic Medicine, Institute of Neuroscience, Autonomous University of Barcelona, 08193 Bellaterra, Barcelona, Spain. lgimenez@servet.uab.es

Strain differences in spontaneous locomotor activity and the behavioral patterns induced by dopaminergic agonists in rodents can disclose differential genetic susceptibilities to dopaminergic dysfunction (i.e. vulnerability to psychosis). Psychogenetic selection of hypoemotional Roman High-Avoidance (RHA) and hyperemotional Low-Avoidance (RLA) rats leads to divergence in dopaminergic function as well. The present study was designed to characterize their spontaneous activity and their responses to apomorphine (0.067-3 mg/kg, s.c.) as compared to those of the standard Sprague-Dawley (SD) strain. The Roman strains displayed higher spontaneous activity than SD rats and RHA exhibited the higher response to novelty which agrees with a higher sensitivity to apomorphine in this strain. The biphasic effect induced by apomorphine (locomotor inhibition and yawning at low doses but stimulation of locomotion and stereotyped behavior at higher ones) was reproduced in the standard SD strain. Low doses were less effective inducing locomotor inhibition in RHA whereas these animals were much more sensitive to high dose-induced stereotyped behavior. In contrast, RLA was characterized as a high-yawning strain and low doses of apomorphine also induced a striking motor inhibition suggesting functional enhancement of dopamine receptors mediating these behaviors. The detailed and distinctive behavioral profiles described in this work suggest between strain differences both at the presynaptic and postsynaptic dopaminergic function and may serve as paths to better specify functional mechanisms in future studies of risk of developing dopaminergic dysfunctions.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D001947 Breeding The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants. Breedings
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
January 1990, Journal of neural transmission. General section,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
May 1986, Pharmacology, biochemistry, and behavior,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
February 1994, Brain research,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
December 1981, Behavioral and neural biology,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
December 1984, Physiology & behavior,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
May 2007, Behavioural pharmacology,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
January 1979, Brain research bulletin,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
November 1997, Behavior genetics,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
July 1983, Behavior genetics,
Lydia Giménez-Llort, and Toni Cañete, and Marc Guitart-Masip, and Alberto Fernández-Teruel, and Adolf Tobeña
December 1981, Experientia,
Copied contents to your clipboard!